ProfileOfResearchers

0
Entrar
- Autenticação Federada (Clique na imagem)
  
  Autenticação local Recuperar Palavra-passe Registar

AuthID: R-000-E2W

Document Source:

Document Type:

Year Start - End:

Order:

Results:

281

TÃTULO: IMPROVEMENT IN QUALITY-OF-LIFE AND DEPRESSIVE SYMPTOMS DURING LONG-TERM TREATMENT WITH ESLICARBAZEPINE ACETATE: BIA-2093-302 STUDY
AUTORES: Patricio Soares da Silva ; Martins da Silva, A; Gabbai, AA; Elinor Ben Menachem; Joyce Cramer; Joana Maia; Almeida, L;
PUBLICAÇÃO: 2008, FONTE: 62nd Annual Meeting of the American-Epilepsy-Society in EPILEPSIA, VOLUME: 49

INDEXADO EM:

WOS

282

TÃTULO: IMPROVEMENT IN QUALITY-OF-LIFE AND DEPRESSIVE SYMPTOMS DURING LONG-TERM TREATMENT WITH ESLICARBAZEPINE ACETATE: BIA-2093-303 STUDY
AUTORES: Henrique Pereira; Lopes Lima, J; Antonio Gil Nagel; Joyce Cramer; Joana Maia; Almeida, L; Patricio Soares da Silva ;
PUBLICAÇÃO: 2008, FONTE: 62nd Annual Meeting of the American-Epilepsy-Society in EPILEPSIA, VOLUME: 49

INDEXADO EM:

WOS

283

TÃTULO: IN VITRO HYDROLYSIS OF ESLICARBAZEPINE ACETATE, A NEW ANTIEPILEPTIC DRUG
AUTORES: Ana Isabel Loureiro; Carlos Fernandes Lopes; Lyndon Wright; Patricio Soares da Silva ;
PUBLICAÇÃO: 2008, FONTE: 10th European Regional Meeting of the International-Society-for-the-Study-of-Xenobiotics in DRUG METABOLISM REVIEWS, VOLUME: 40

INDEXADO EM:

WOS

284

TÃTULO: LONG-TERM TREATMENT OF PARTIAL EPILEPSY WITH ESLICARBAZEPINE ACETATE (ESL): RESULTS OF A ONE-YEAR OPEN-LABEL EXTENSION OF STUDY BIA-2093-302
AUTORES: Gabbai, AA; Elinor Ben Menachem; Joana Maia; Almeida, L; Soares da Silva, P ;
PUBLICAÇÃO: 2008, FONTE: 62nd Annual Meeting of the American-Epilepsy-Society in EPILEPSIA, VOLUME: 49

INDEXADO EM:

WOS

285

TÃTULO: LONG-TERM TREATMENT OF PARTIAL EPILEPSY WITH ESLICARBAZEPINE ACETATE (ESL): RESULTS OF A ONE-YEAR OPEN-LABEL EXTENSION OF STUDY BIA-2093-303
AUTORES: Lopes Lima, J; Antonio Gil Nagel; Joana Maia; Almeida, L; Patricio Soares da Silva ;
PUBLICAÇÃO: 2008, FONTE: 62nd Annual Meeting of the American-Epilepsy-Society in EPILEPSIA, VOLUME: 49

INDEXADO EM:

WOS

286

TÃTULO: LONG-TERM TREATMENT OF PARTIAL EPILEPSY WITH ESLICARBAZEPINE ACETATE (ESL): RESULTS OF A ONE-YEAR OPEN-LABEL EXTENSION TO STUDY BIA-2093-301
AUTORES: Halasz, P; Elger, C; Guekht, A; Joana Maia; Almeida, L; Soares da Silva, P ;
PUBLICAÇÃO: 2008, FONTE: 62nd Annual Meeting of the American-Epilepsy-Society in EPILEPSIA, VOLUME: 49

INDEXADO EM:

WOS

287

TÃTULO: Metabolic profile of eslicarbazepine acetate in mice and the role of liver in the systemic drug exposure Full Text
AUTORES: Alves, G; Falcao, A; Figueiredo, I; Castel Branco, M; Caramona, M; Soares da Silva, P ;
PUBLICAÇÃO: 2008, FONTE: 21st Congress of the European-College-of-Neuropsychopharmacology in EUROPEAN NEUROPSYCHOPHARMACOLOGY, VOLUME: 18

INDEXADO EM:

WOS

288

TÃTULO: Non-Drug Adverse Symptoms are Influenced by the Personality Trait Anxiety
AUTORES: Almeida, L; Gama, H; Vaz da Silva, M; Nunes, T; Coelho, R; Albino Teixeiro, A; Soares da Silva, P ;
PUBLICAÇÃO: 2008, FONTE: 8th Annual Meeting of the International-Society-of Pharmacovigilance (ISoP) in DRUG SAFETY, VOLUME: 31, NÚMERO: 10

INDEXADO EM:

WOS

289

TÃTULO: Non-Drug Related Adverse Complaints in Volunteers to Phase I Studies and in Normal Population
AUTORES: Almeida, L; Gama, H; Nunes, T; Coelho, R; Vaz da Silva, M; Albino Teixeira, A; Soares da Silva, P ;
PUBLICAÇÃO: 2008, FONTE: 8th Annual Meeting of the International-Society-of Pharmacovigilance (ISoP) in DRUG SAFETY, VOLUME: 31, NÚMERO: 10

INDEXADO EM:

WOS

290